Ben Phillis

Ben is Head of Extension Fund at UniQuest.

Prior to UniQuest, Ben worked in a number of roles for Mayne Pharma in innovation and business development and has experience in pharmaceutics, modified release formulations, ‘super-generics’ and pharmaceutical product life-cycle management.

Ben has a research background in pharmacology and toxicology and holds a Ph.D. (Med.) from The University of Adelaide. His dissertation was concerned with cardiotoxicity associated with drugs of abuse. He completed a post-doctoral fellowship in neuropharmacology at the Hanson Institute, working on a drug discovery program funded by AstraZeneca.